How brain support cells (glia) may cause medulloblastoma to come back
Glial Origin and Signaling in Medulloblastoma
Researchers are looking at whether a type of brain support cell called glial progenitors helps medulloblastoma return after treatment in children.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Cincinnati Childrens Hosp Med Ctr NIH-funded |
| Lab location | 1 site (Cincinnati, United States) |
| Project ID | NIH-11238534 on NIH RePORTER |
What this research studies
This project uses detailed single-cell analysis of tumor samples and laboratory models to find the specific cells that seed medulloblastoma regrowth. The team focuses on OLIG2-expressing glial progenitors that increase after chemotherapy in animal models and human recurrent tumors. They will study the signaling pathways these cells use to survive and repopulate tumors, and test targets in preclinical models. The goal is to identify strategies that could stop relapse while sparing healthy brain tissue.
Who could benefit from this research
Good fit: Children with sonic hedgehog (SHH)–subtype medulloblastoma, especially those undergoing surgery or with recurrent disease who can donate tumor tissue, would be most relevant to this work.
Not a fit: People with unrelated neurological conditions, other medulloblastoma subtypes not driven by the same pathway, or those unable to provide tumor samples are unlikely to benefit directly in the near term.
Why it matters
Potential benefit: If successful, this work could lead to therapies that prevent medulloblastoma relapse and improve survival with fewer long-term side effects.
How similar studies have performed: Laboratory and animal studies have previously shown OLIG2-positive cells can drive tumor growth, but targeting these glial progenitors in patients is still largely untested.
Where this research is happening
Cincinnati, United States
- Cincinnati Childrens Hosp Med Ctr — Cincinnati, United States (Active)
Researchers
- Principal investigator: Lu, Qing Richard — Cincinnati Childrens Hosp Med Ctr
- Study coordinator: Lu, Qing Richard
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.